The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience

Critical Care Medicine

Volumn 39, Issue 9, 2011, Pages 2072-2079

  Engström, Annemarie E ^a   Cocchieri, Ricardo ^a   Driessen, Antoine H ^a   Sjauw, Krischan D ^a   Vis, Marije M ^a   Baan, Jan ^a   De Jong, Mark ^a   Lagrand, Wim K ^a   Van Der Sloot, Jos A P ^a   Tijssen, Jan G ^a   De Winter, Robbert J ^a   De Mol, Bas A S ^a   Piek, Jan J ^a   Henriques, José P J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

cardiogenic shock; intensive care medicine; mechanical circulatory support

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HYPERTENSIVE AGENT; INOTROPIC AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; IMPELLA SYSTEM; IMPLANT; INTENSIVE CARE UNIT; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 80051940024     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821e89b5     Document Type: Article

References (22)

1. Hochman JS, Sleeper LA, Webb JG, et al: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341:625-634
2. Jeger RV, Radovanovic D, Hunziker PR, et al: Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 2008; 149:618-626
3. Kantrowitz A, Tjonneland S, Freed PS, et al: Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968; 203:113-118
4. Antman EM, Anbe DT, Armstrong PW, et al: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: E1-E211
5. Sjauw KD, Engström AE, Vis MM, et al: A systematic review and meta-analysis of intraaortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J 2009; 30:459-468
6. Lam K, Sjauw KD, van der Meulen J, et al: A combined surgical and percutaneous approach through the axillary artery to introduce the Impella LP5.0 for short-term circulatory support. Int J Cardiol 2009; 134: 277-279
7. Henriques JP, de Mol BA: New percutaneous mechanical left ventricular support for acute MI: The AMC MACH program. Nat Clin Pract Cardiovasc Med 2008; 5:62-63 (Pubitemid 351168055)
8. Henriques JP, Remmelink M, Baan J Jr, et al: Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006; 97:990-992
9. Sjauw KD, Konorza T, Erbel R, et al: Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol 2009; 54:2430-2434
10. Dixon SR, Henriques JP, Mauri L, et al: A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): Initial U.S. experience. JACC Cardiovasc Interv 2009; 2:91-96
11. Sjauw KD, Remmelink M, Baan J Jr, et al: Left ventricular unloading in acute STsegment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol 2008; 51:1044-1046 (Pubitemid 351318126)
12. Remmelink M, Sjauw KD, Henriques JP, et al: Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv 2010; 75:187-194
13. Tayara W, Starling RC, Yamani MH, et al: Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: Comparing aggressive intervention with conservative treatment. J Heart Lung Transplant 2006; 25:504-509 (Pubitemid 44308155)
14. Anderson M, Smedira N, Samuels L, et al: Use of the AB5000 ventricular assist device in cardiogenic shock after acute myocardial infarction. Ann Thorac Surg 2010; 90:706-712
15. Rastan AJ, Dege A, Mohr M, et al: Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010; 139:302-311, 311.e1
16. Thiele H, Sick P, Boudriot E, et al: Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26: 1276-1283 (Pubitemid 41435457)
17. Burkhoff D, Cohen H, Brunckhorst C, et al: A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: 469.e1-469.e8
18. Meyns B, Stolinski J, Leunens V, et al: Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 2003; 41:1087-1095 (Pubitemid 36384893)
19. Meyns B, Dens J, Sergeant P, et al: Initial experiences with the Impella device in patients with cardiogenic shock-Impella support for cardiogenic shock. Thorac Cardiovasc Surg 2003; 51:312-317 (Pubitemid 38031386)
20. Seyfarth M, Sibbing D, Bauer I, et al: A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52:1584-1588
21. Engström A, Sjauw K, Baan J, et al: Longterm safety and sustained left ventricular recovery: Long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction. Euro-Intervention 2011; 6:860-865
22. Tuseth V, Pettersen RJ, Epstein A, et al: Percutaneous left ventricular assist device can prevent acute cerebral ischaemia during ventricular fibrillation. Resuscitation 2009; 80: 1197-1203